Milk Thistle and Prostate Cancer: Differential Effects of Pure Flavonolignans from Silybum marianum on Antiproliferative End Points in Human Prostate Carcinoma Cells
- 15 May 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (10) , 4448-4457
- https://doi.org/10.1158/0008-5472.can-04-4662
Abstract
Extracts from the seeds of milk thistle, Silybum marianum, are known commonly as silibinin and silymarin and possess anticancer actions on human prostate carcinoma in vitro and in vivo. Seven distinct flavonolignan compounds and a flavonoid have been isolated from commercial silymarin extracts. Most notably, two pairs of diastereomers, silybin A and silybin B and isosilybin A and isosilybin B, are among these compounds. In contrast, silibinin is composed only of a 1:1 mixture of silybin A and silybin B. With these isomers now isolated in quantities sufficient for biological studies, each pure compound was assessed for antiproliferative activities against LNCaP, DU145, and PC3 human prostate carcinoma cell lines. Isosilybin B was the most consistently potent suppressor of cell growth relative to either the other pure constituents or the commercial extracts. Isosilybin A and isosilybin B were also the most effective suppressors of prostate-specific antigen secretion by androgen-dependent LNCaP cells. Silymarin and silibinin were shown for the first time to suppress the activity of the DNA topoisomerase IIα gene promoter in DU145 cells and, among the pure compounds, isosilybin B was again the most effective. These findings are significant in that isosilybin B composes no more than 5% of silymarin and is absent from silibinin. Whereas several other more abundant flavonolignans do ultimately influence the same end points at higher exposure concentrations, these findings are suggestive that extracts enriched for isosilybin B, or isosilybin B alone, might possess improved potency in prostate cancer prevention and treatment.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin‐ and carboplatin‐induced growth inhibition and apoptotic deathInternational Journal of Cancer, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cellsThe Prostate, 2002
- Flavonoid Antioxidant Silymarin and Skin CancerAntioxidants and Redox Signaling, 2002
- The Cancer Preventive Flavonoid Silibinin Causes Hypophosphorylation of Rb/p107 and Rb2/p130 Via Modulation of Cell Cycle Regulators in Human Prostate Carcinoma DU145 CellsCell Cycle, 2002
- Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cellsProstate Cancer and Prostatic Diseases, 2001
- Inhibitory effect of silymarin, an anti-hepatotoxic flavonoid, on 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and mRNA in SENCAR miceCarcinogenesis: Integrative Cancer Research, 1994
- Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjectsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1990
- Constituents of Silybum marianum. Structure of isosilybin and stereochemistry of silybinJournal of the Chemical Society, Chemical Communications, 1979
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971